World experts in neurodegenerative diseases gathered at Weill Cornell Medicine Sept. 25 to present the latest discoveries in the study and treatment of Alzheimer's disease.
As therapies for HIV have advanced to help many patients control the infection as a chronic disease, investigators and patients have set their sights on a new goal: finding a cure. Drs. Douglas Nixon and Brad Jones have recently joined Weill Cornell Medicine in the hopes of accelerating that hunt.
Researchers in the lab of Charles Danko have developed a new tool to study genetic “switches” active in glioblastoma tumors that drive growth of the cancer.
C. Richard Johnson will speak about the field of computational art history and discuss preserving and authenticating the works of Vermeer and Rembrandt Nov. 9.
Experts will discuss the role of energy startups, new investment strategies and the impact investing will play in shaping the future of the energy industry Nov. 2.
The new Blockchain for Business certificate program helps learners explore blockchain’s cryptographic roots, demystify the technology and use blockchain to solve business problems.
